<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03216902</url>
  </required_header>
  <id_info>
    <org_study_id>012601IN</org_study_id>
    <nct_id>NCT03216902</nct_id>
  </id_info>
  <brief_title>A Phase IIb Safety and Efficacy Study of DE-126 Ophthalmic Solution in Primary Open-Angle Glaucoma or Ocular Hypertension- Angel Study</brief_title>
  <official_title>A Phase IIb, Randomized, Observer-Masked, Placebo- and Active-Controlled, Parallel-Group, Multinational and Multicenter Study Assessing the Safety and Efficacy of DE-126 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension- Angel Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Santen Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Santen Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Treatment of elevated pressure in the eye (Intraocular pressure, or 'IOP') with eye drop&#xD;
      medications has been shown to be effective in delaying or preventing the progression of&#xD;
      glaucoma, and it is the only proven method for reducing the risk of glaucomatous visual field&#xD;
      loss.&#xD;
&#xD;
      This study is being conducted to determine how well DE-126 ophthalmic solution works&#xD;
      (efficacy) in safely lowering IOP when dosed as topical eyedrops. This study will evaluate&#xD;
      the safety and efficacy of four (4) concentrations of DE-126, when compared with latanoprost&#xD;
      (0.005%) eye drops in patients with primary open-angle glaucoma or ocular hypertension.&#xD;
&#xD;
      The IOP will be measured at 3 different times throughout the day, over 6 total visits during&#xD;
      a 3-month treatment period (with up to 4 extra weeks observation if the patient must stop&#xD;
      taking current eye drops to lower IOP). Safety assessments will be done throughout the study,&#xD;
      including ocular signs and symptoms, vital signs, and clinical laboratory tests. While the&#xD;
      most important time-point to measure IOP in this study and evaluate efficacy will be at the&#xD;
      final study visit (month 3), IOP values will also be evaluated at other visits throughout the&#xD;
      3-month treatment period.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 25, 2017</start_date>
  <completion_date type="Actual">February 27, 2018</completion_date>
  <primary_completion_date type="Actual">February 27, 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intraocular Pressure in the Study Eye at Month 3</measure>
    <time_frame>9:00, 13:00 and 17:00 at Month 3</time_frame>
    <description>Intraocular Pressure (IOP),the fluid pressure inside the eye was measured by the Goldmann applanation tonometer in millimeters mercury (mmHg) at 3 time-points throughout the day.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intraocular Pressure in the Study Eye at Week 6</measure>
    <time_frame>9:00, 13:00 and 17:00 at Week 6</time_frame>
    <description>Intraocular Pressure (IOP),the fluid pressure inside the eye was measured by the Goldmann applanation tonometer in millimeters mercury (mmHg) at 3 time-points throughout the day.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraocular Pressure in the Study Eye at Week 1 and Week 2</measure>
    <time_frame>9:00, 13:00 and 17:00 at Week 1 and Week 2</time_frame>
    <description>Intraocular Pressure (IOP),the fluid pressure inside the eye was measured by the Goldmann applanation tonometer in millimeters mercury (mmHg) at 3 time-points throughout the day.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Diurnal Intraocular Pressure in the Study Eye at Each Post-baseline Visit</measure>
    <time_frame>Week 1, Week 2, Week 6 and Month 3.</time_frame>
    <description>Mean Diurnal IOP was defined as the mean of the IOP values at the three schedules timepoints (9:00, 13:00 and 17:00) at that visit for that subject.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline (CFB) in Mean Diurnal Intraocular Pressure in the Study Eye at Each Post-baseline Visit</measure>
    <time_frame>Week 1, Week 2, Week 6 and Month 3.</time_frame>
    <description>Mean Diurnal IOP was defined as the mean of the IOP values at the three schedules timepoints (9:00, 13:00 and 17:00) at that visit for that subject.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent Change From Baseline (CFB) in Mean Diurnal Intraocular Pressure in the Study Eye at Each Post-baseline Visit</measure>
    <time_frame>Week 1, Week 2, Week 6 and Month 3.</time_frame>
    <description>Mean Diurnal IOP was defined as the mean of the IOP values at the three schedules timepoints (9:00, 13:00 and 17:00) at that visit for that subject.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline (CFB) in Intraocular Pressure in the Study Eye at Three Time Points at Each Post-baseline Visit</measure>
    <time_frame>9:00, 13:00 and 17:00 at Week 1, Week 2, Week 6 and Month 3.</time_frame>
    <description>Intraocular Pressure (IOP),the fluid pressure inside the eye was measured by the Goldmann applanation tonometer in millimeters mercury (mmHg) at 3 time-points throughout the day.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent Change From Baseline (CFB) in Intraocular Pressure in the Study Eye at Three Time Points at Each Post-baseline Visit</measure>
    <time_frame>9:00, 13:00 and 17:00 at Week 1, Week 2, Week 6 and Month 3.</time_frame>
    <description>Intraocular Pressure (IOP),the fluid pressure inside the eye was measured by the Goldmann applanation tonometer in millimeters mercury (mmHg) at 3 time-points throughout the day.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Subjects With Mean Diurnal Intraocular Pressure Reduction From Baseline ≥ 20%, 25% and 30% in the Study Eye at Each Post-baseline Visit</measure>
    <time_frame>WeeK 1, Week 2, Week 6 and Month 3.</time_frame>
    <description>A Subject was a responder if the percent reduction from baseline in mean diurnal IOP in the study eye was ≥ 20%.&#xD;
A Subject was a responder if the percent reduction from baseline in mean diurnal IOP in the study eye was ≥ 25%.&#xD;
A Subject was a responder if the percent reduction from baseline in mean diurnal IOP in the study eye was ≥ 30%.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Subjects With Mean Diurnal Intraocular Pressure ≤ 18 mmHg in the Study Eye at Each Post-baseline Visit</measure>
    <time_frame>Week 1, Week 2, Week 6 and Month 3.</time_frame>
    <description>A subject was a responder if the mean diurnal IOP in the study eye was ≤ 18 mmHg.</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">241</enrollment>
  <condition>Open-angle Glaucoma, Ocular Hypertension</condition>
  <arm_group>
    <arm_group_label>Placebo (Vehicle of DE-126) followed by high dose of DE-126</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Ultra-low dose 0.0005% DE-126</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Low dose 0.001% DE-126</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Medium dose 0.002% DE-126</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>High dose 0.003% DE-126</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>0.005% Latanoprost</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vehicle of DE-126 Ophthalmic Solution, high dose of DE-126 Ophthalmic Solution</intervention_name>
    <description>Vehicle of DE-126 Ophthalmic Solution dosed once daily for 6weeks, followed by high dose of DE-126 dosed once daily for 6 additional weeks</description>
    <arm_group_label>Placebo (Vehicle of DE-126) followed by high dose of DE-126</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Topical ultra-low dose of DE-126 Ophthalmic Solution</intervention_name>
    <description>Topical ultra-low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
    <arm_group_label>Ultra-low dose 0.0005% DE-126</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Topical low dose of DE-126 Ophthalmic Solution</intervention_name>
    <description>Topical low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
    <arm_group_label>Low dose 0.001% DE-126</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Topical medium dose of DE-126 Ophthalmic Solution</intervention_name>
    <description>Topical medium dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
    <arm_group_label>Medium dose 0.002% DE-126</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Topical high dose of DE-126 Ophthalmic Solution</intervention_name>
    <description>Topical high dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
    <arm_group_label>High dose 0.003% DE-126</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.005% Latanoprost Ophthalmic Solution</intervention_name>
    <description>0.005% Latanoprost Ophthalmic Solution dosed once daily for 12 weeks</description>
    <arm_group_label>0.005% Latanoprost</arm_group_label>
    <other_name>Xalatan®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Provide signed written informed consent&#xD;
&#xD;
          -  Diagnosis of POAG or OHT in both eyes&#xD;
&#xD;
          -  Qualifying corrected visual acuity in each eye&#xD;
&#xD;
          -  Qualifying central corneal thickness in each eye&#xD;
&#xD;
          -  Qualifying Day 1 IOP measurement at 3 time-points in both eyes&#xD;
&#xD;
          -  Qualifying Anterior chamber angle&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of ocular surgery specifically intended to lower IOP&#xD;
&#xD;
          -  Subjects who cannot safely discontinue use of ocular hypotensive medications during&#xD;
             the wait/washout period&#xD;
&#xD;
          -  Advanced glaucoma in either eye&#xD;
&#xD;
          -  Any corneal abnormality or other condition interfering with or preventing reliable&#xD;
             Goldmann applanation tonometry&#xD;
&#xD;
          -  Any ocular surgery or ocular laser treatment within 90 days prior to Visit 1&#xD;
             (Screening) and throughout the study in either eye&#xD;
&#xD;
          -  Females who are pregnant, nursing, or planning a pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Sall Research Medical Center, Inc</name>
      <address>
        <city>Artesia</city>
        <state>California</state>
        <zip>90701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Valley Eye Medical Group</name>
      <address>
        <city>Mission Hills</city>
        <state>California</state>
        <zip>91345</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eye Research Foundation, INC</name>
      <address>
        <city>Newport Beach</city>
        <state>California</state>
        <zip>92657</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Bay Eye Associates, Inc.</name>
      <address>
        <city>Petaluma</city>
        <state>California</state>
        <zip>94954</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shettle Eye Research, Inc.</name>
      <address>
        <city>Largo</city>
        <state>Florida</state>
        <zip>33773</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clayton Eye Clinical Research, LLC</name>
      <address>
        <city>Morrow</city>
        <state>Georgia</state>
        <zip>30260</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Coastal Research Associates, LLC</name>
      <address>
        <city>Roswell</city>
        <state>Georgia</state>
        <zip>30076</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rochester Ophthalmological Group, PC</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14618</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mundorf Eye Center</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cornerstone Health Care, LLC</name>
      <address>
        <city>High Point</city>
        <state>North Carolina</state>
        <zip>27262</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Keystone Research Ltd SMO/Texan Eye, PA</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78731</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Keystone Research LTD SMO/Medical Center Ophthalmology Assoc.</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78240</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Murakami Karindoh Hospital</name>
      <address>
        <city>Fukuoka-shi, Fukuoka</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nagasaka Eye Clinic</name>
      <address>
        <city>Nagoya-shi, Aichi</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sugiura Eye Clinic</name>
      <address>
        <city>Osaka-shi, Osaka</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sapporo Katoh Ophthalmology Clinic</name>
      <address>
        <city>Sapporo-shi, Hokkaido</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dogenzaka Kato Eye Clinic</name>
      <address>
        <city>Shibuya-ku, Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>July 11, 2017</study_first_submitted>
  <study_first_submitted_qc>July 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 13, 2017</study_first_posted>
  <results_first_submitted>August 21, 2020</results_first_submitted>
  <results_first_submitted_qc>September 30, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">October 23, 2020</results_first_posted>
  <last_update_submitted>September 30, 2020</last_update_submitted>
  <last_update_submitted_qc>September 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Glaucoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
    <mesh_term>Ocular Hypertension</mesh_term>
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Latanoprost</mesh_term>
    <mesh_term>Ophthalmic Solutions</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>June 16, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/02/NCT03216902/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 27, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/02/NCT03216902/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Placebo (Vehicle of DE-126) Followed by High Dose of DE-126</title>
          <description>Vehicle of DE-126 Ophthalmic Solution, high dose of DE-126 Ophthalmic Solution: Vehicle of DE-126 Ophthalmic Solution dosed once daily for 6weeks, followed by high dose of DE-126 dosed once daily for 6 additional weeks</description>
        </group>
        <group group_id="P2">
          <title>0.005% Latanoprost</title>
          <description>0.005% Latanoprost Ophthalmic Solution: 0.005% Latanoprost Ophthalmic Solution dosed once daily for 12 weeks</description>
        </group>
        <group group_id="P3">
          <title>Ultra-low Dose 0.0005% DE-126</title>
          <description>Topical ultra-low dose of DE-126 Ophthalmic Solution: Topical ultra-low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
        </group>
        <group group_id="P4">
          <title>Low Dose 0.001% DE-126</title>
          <description>Topical low dose of DE-126 Ophthalmic Solution: Topical low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
        </group>
        <group group_id="P5">
          <title>Medium Dose 0.002% DE-126</title>
          <description>Topical medium dose of DE-126 Ophthalmic Solution: Topical medium dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
        </group>
        <group group_id="P6">
          <title>High Dose 0.003% DE-126</title>
          <description>Topical high dose of DE-126 Ophthalmic Solution: Topical high dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="44"/>
                <participants group_id="P3" count="43"/>
                <participants group_id="P4" count="43"/>
                <participants group_id="P5" count="44"/>
                <participants group_id="P6" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="43"/>
                <participants group_id="P3" count="42"/>
                <participants group_id="P4" count="43"/>
                <participants group_id="P5" count="43"/>
                <participants group_id="P6" count="42"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Placebo (Vehicle of DE-126) Followed by High Dose of DE-126</title>
          <description>Vehicle of DE-126 Ophthalmic Solution, high dose of DE-126 Ophthalmic Solution: Vehicle of DE-126 Ophthalmic Solution dosed once daily for 6weeks, followed by high dose of DE-126 dosed once daily for 6 additional weeks</description>
        </group>
        <group group_id="B2">
          <title>0.005% Latanoprost</title>
          <description>0.005% Latanoprost Ophthalmic Solution: 0.005% Latanoprost Ophthalmic Solution dosed once daily for 12 weeks</description>
        </group>
        <group group_id="B3">
          <title>Ultra-low Dose 0.0005% DE-126</title>
          <description>Topical ultra-low dose of DE-126 Ophthalmic Solution: Topical ultra-low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
        </group>
        <group group_id="B4">
          <title>Low Dose 0.001% DE-126</title>
          <description>Topical low dose of DE-126 Ophthalmic Solution: Topical low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
        </group>
        <group group_id="B5">
          <title>Medium Dose 0.002% DE-126</title>
          <description>Topical medium dose of DE-126 Ophthalmic Solution: Topical medium dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
        </group>
        <group group_id="B6">
          <title>High Dose 0.003% DE-126</title>
          <description>Topical high dose of DE-126 Ophthalmic Solution: Topical high dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
        </group>
        <group group_id="B7">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="22"/>
            <count group_id="B2" value="44"/>
            <count group_id="B3" value="43"/>
            <count group_id="B4" value="43"/>
            <count group_id="B5" value="44"/>
            <count group_id="B6" value="45"/>
            <count group_id="B7" value="241"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.2" spread="11.24"/>
                    <measurement group_id="B2" value="64.4" spread="9.8"/>
                    <measurement group_id="B3" value="65.5" spread="13.30"/>
                    <measurement group_id="B4" value="63.7" spread="9.41"/>
                    <measurement group_id="B5" value="61.0" spread="11.84"/>
                    <measurement group_id="B6" value="63.8" spread="11.84"/>
                    <measurement group_id="B7" value="63.6" spread="11.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="26"/>
                    <measurement group_id="B4" value="22"/>
                    <measurement group_id="B5" value="25"/>
                    <measurement group_id="B6" value="25"/>
                    <measurement group_id="B7" value="135"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="17"/>
                    <measurement group_id="B4" value="21"/>
                    <measurement group_id="B5" value="19"/>
                    <measurement group_id="B6" value="20"/>
                    <measurement group_id="B7" value="106"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="5"/>
                    <measurement group_id="B6" value="6"/>
                    <measurement group_id="B7" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="36"/>
                    <measurement group_id="B4" value="36"/>
                    <measurement group_id="B5" value="39"/>
                    <measurement group_id="B6" value="39"/>
                    <measurement group_id="B7" value="209"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Japan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="20"/>
                    <measurement group_id="B4" value="20"/>
                    <measurement group_id="B5" value="21"/>
                    <measurement group_id="B6" value="21"/>
                    <measurement group_id="B7" value="114"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="23"/>
                    <measurement group_id="B4" value="23"/>
                    <measurement group_id="B5" value="23"/>
                    <measurement group_id="B6" value="24"/>
                    <measurement group_id="B7" value="127"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Intraocular Pressure in the Study Eye at Month 3</title>
        <description>Intraocular Pressure (IOP),the fluid pressure inside the eye was measured by the Goldmann applanation tonometer in millimeters mercury (mmHg) at 3 time-points throughout the day.</description>
        <time_frame>9:00, 13:00 and 17:00 at Month 3</time_frame>
        <population>The number of participants is reduced due to missing data.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo (Vehicle of DE-126) Followed by High Dose of DE-126</title>
            <description>Vehicle of DE-126 Ophthalmic Solution, high dose of DE-126 Ophthalmic Solution: Vehicle of DE-126 Ophthalmic Solution dosed once daily for 6weeks, followed by high dose of DE-126 dosed once daily for 6 additional weeks</description>
          </group>
          <group group_id="O2">
            <title>0.005% Latanoprost</title>
            <description>0.005% Latanoprost Ophthalmic Solution: 0.005% Latanoprost Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O3">
            <title>Ultra-low Dose 0.0005% DE-126</title>
            <description>Topical ultra-low dose of DE-126 Ophthalmic Solution: Topical ultra-low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O4">
            <title>Low Dose 0.001% DE-126</title>
            <description>Topical low dose of DE-126 Ophthalmic Solution: Topical low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O5">
            <title>Medium Dose 0.002% DE-126</title>
            <description>Topical medium dose of DE-126 Ophthalmic Solution: Topical medium dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O6">
            <title>High Dose 0.003% DE-126</title>
            <description>Topical high dose of DE-126 Ophthalmic Solution: Topical high dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Intraocular Pressure in the Study Eye at Month 3</title>
          <description>Intraocular Pressure (IOP),the fluid pressure inside the eye was measured by the Goldmann applanation tonometer in millimeters mercury (mmHg) at 3 time-points throughout the day.</description>
          <population>The number of participants is reduced due to missing data.</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="44"/>
                <count group_id="O3" value="43"/>
                <count group_id="O4" value="43"/>
                <count group_id="O5" value="44"/>
                <count group_id="O6" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>9:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.8" spread="4.11"/>
                    <measurement group_id="O2" value="18.1" spread="3.73"/>
                    <measurement group_id="O3" value="19.7" spread="3.27"/>
                    <measurement group_id="O4" value="19.2" spread="3.37"/>
                    <measurement group_id="O5" value="17.6" spread="3.13"/>
                    <measurement group_id="O6" value="19.3" spread="2.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>13:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.6" spread="3.18"/>
                    <measurement group_id="O2" value="17.3" spread="3.01"/>
                    <measurement group_id="O3" value="18.5" spread="2.98"/>
                    <measurement group_id="O4" value="18.1" spread="2.99"/>
                    <measurement group_id="O5" value="17.4" spread="2.39"/>
                    <measurement group_id="O6" value="18.7" spread="3.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>17:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.8" spread="2.87"/>
                    <measurement group_id="O2" value="17.2" spread="3.10"/>
                    <measurement group_id="O3" value="18.3" spread="2.55"/>
                    <measurement group_id="O4" value="17.8" spread="2.93"/>
                    <measurement group_id="O5" value="16.7" spread="2.74"/>
                    <measurement group_id="O6" value="17.9" spread="2.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intraocular Pressure in the Study Eye at Week 6</title>
        <description>Intraocular Pressure (IOP),the fluid pressure inside the eye was measured by the Goldmann applanation tonometer in millimeters mercury (mmHg) at 3 time-points throughout the day.</description>
        <time_frame>9:00, 13:00 and 17:00 at Week 6</time_frame>
        <population>The number of participants is reduced due to missing data. This endpoint is to test if one of four concentrations of DE-126 is superior to the placebo in lowering IOP at each specified timepoint (9:00, 13:00 and 17:00) at Week 6 compared to baseline. Therefore, 0.005% Latanoprost group is not included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo (Vehicle of DE-126) Followed by High Dose of DE-126</title>
            <description>Vehicle of DE-126 Ophthalmic Solution, high dose of DE-126 Ophthalmic Solution: Vehicle of DE-126 Ophthalmic Solution dosed once daily for 6weeks, followed by high dose of DE-126 dosed once daily for 6 additional weeks</description>
          </group>
          <group group_id="O2">
            <title>Ultra-low Dose 0.0005% DE-126</title>
            <description>Topical ultra-low dose of DE-126 Ophthalmic Solution: Topical ultra-low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O3">
            <title>Low Dose 0.001% DE-126</title>
            <description>Topical low dose of DE-126 Ophthalmic Solution: Topical low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O4">
            <title>Medium Dose 0.002% DE-126</title>
            <description>Topical medium dose of DE-126 Ophthalmic Solution: Topical medium dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O5">
            <title>High Dose 0.003% DE-126</title>
            <description>Topical high dose of DE-126 Ophthalmic Solution: Topical high dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Intraocular Pressure in the Study Eye at Week 6</title>
          <description>Intraocular Pressure (IOP),the fluid pressure inside the eye was measured by the Goldmann applanation tonometer in millimeters mercury (mmHg) at 3 time-points throughout the day.</description>
          <population>The number of participants is reduced due to missing data. This endpoint is to test if one of four concentrations of DE-126 is superior to the placebo in lowering IOP at each specified timepoint (9:00, 13:00 and 17:00) at Week 6 compared to baseline. Therefore, 0.005% Latanoprost group is not included in the analysis.</population>
          <units>mmHg</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="43"/>
                <count group_id="O4" value="44"/>
                <count group_id="O5" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>9:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="42"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.2" spread="0.66"/>
                    <measurement group_id="O2" value="19.0" spread="0.46"/>
                    <measurement group_id="O3" value="18.5" spread="0.46"/>
                    <measurement group_id="O4" value="18.7" spread="0.45"/>
                    <measurement group_id="O5" value="18.7" spread="0.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>13:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="42"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.2" spread="0.61"/>
                    <measurement group_id="O2" value="18.2" spread="0.42"/>
                    <measurement group_id="O3" value="17.9" spread="0.42"/>
                    <measurement group_id="O4" value="17.3" spread="0.42"/>
                    <measurement group_id="O5" value="17.5" spread="0.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>17:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="42"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.6" spread="0.62"/>
                    <measurement group_id="O2" value="17.8" spread="0.43"/>
                    <measurement group_id="O3" value="17.9" spread="0.43"/>
                    <measurement group_id="O4" value="16.6" spread="0.42"/>
                    <measurement group_id="O5" value="17.4" spread="0.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>This endpoint is to test if one of four concentrations of DE-126 is superior to the placebo in lowering IOP at each specified timepoint (9:00, 13:00 and 17:00) at Week 6 compared to baseline. Therefore, 0.005% Latanoprost group is not included in the analysis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Claim superiority of DE-126 compare to Placebo at 3 timepoints (9:00, 13:00 and 17:00)</non_inferiority_desc>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>P value is adjusted for multiple comparisons using Hochberg step-up procedure.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>This endpoint is to test if one of four concentrations of DE-126 is superior to the placebo in lowering IOP at each specified timepoint (9:00, 13:00 and 17:00) at Week 6 compared to baseline. Therefore, 0.005% Latanoprost group is not included in the analysis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Claim superiority of DE-126 compare to Placebo at 3 timepoints (9:00, 13:00 and 17:00)</non_inferiority_desc>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>P value is adjusted for multiple comparisons using Hochberg step-up procedure.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>This endpoint is to test if one of four concentrations of DE-126 is superior to the placebo in lowering IOP at each specified timepoint (9:00, 13:00 and 17:00) at Week 6 compared to baseline. Therefore, 0.005% Latanoprost group is not included in the analysis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Claim superiority of DE-126 compare to Placebo at 3 timepoints (9:00, 13:00 and 17:00)</non_inferiority_desc>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>P value is adjusted for multiple comparisons using Hochberg step-up procedure.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>This endpoint is to test if one of four concentrations of DE-126 is superior to the placebo in lowering IOP at each specified timepoint (9:00, 13:00 and 17:00) at Week 6 compared to baseline. Therefore, 0.005% Latanoprost group is not included in the analysis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Claim superiority of DE-126 compare to Placebo at 3 timepoints (9:00, 13:00 and 17:00)</non_inferiority_desc>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>P value is adjusted for multiple comparisons using Hochberg step-up procedure.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intraocular Pressure in the Study Eye at Week 1 and Week 2</title>
        <description>Intraocular Pressure (IOP),the fluid pressure inside the eye was measured by the Goldmann applanation tonometer in millimeters mercury (mmHg) at 3 time-points throughout the day.</description>
        <time_frame>9:00, 13:00 and 17:00 at Week 1 and Week 2</time_frame>
        <population>The number of participants is reduced due to missing data.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo (Vehicle of DE-126) Followed by High Dose of DE-126</title>
            <description>Vehicle of DE-126 Ophthalmic Solution, high dose of DE-126 Ophthalmic Solution: Vehicle of DE-126 Ophthalmic Solution dosed once daily for 6weeks, followed by high dose of DE-126 dosed once daily for 6 additional weeks</description>
          </group>
          <group group_id="O2">
            <title>0.005% Latanoprost</title>
            <description>0.005% Latanoprost Ophthalmic Solution: 0.005% Latanoprost Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O3">
            <title>Ultra-low Dose 0.0005% DE-126</title>
            <description>Topical ultra-low dose of DE-126 Ophthalmic Solution: Topical ultra-low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O4">
            <title>Low Dose 0.001% DE-126</title>
            <description>Topical low dose of DE-126 Ophthalmic Solution: Topical low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O5">
            <title>Medium Dose 0.002% DE-126</title>
            <description>Topical medium dose of DE-126 Ophthalmic Solution: Topical medium dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O6">
            <title>High Dose 0.003% DE-126</title>
            <description>Topical high dose of DE-126 Ophthalmic Solution: Topical high dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Intraocular Pressure in the Study Eye at Week 1 and Week 2</title>
          <description>Intraocular Pressure (IOP),the fluid pressure inside the eye was measured by the Goldmann applanation tonometer in millimeters mercury (mmHg) at 3 time-points throughout the day.</description>
          <population>The number of participants is reduced due to missing data.</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="44"/>
                <count group_id="O3" value="43"/>
                <count group_id="O4" value="43"/>
                <count group_id="O5" value="44"/>
                <count group_id="O6" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Week1 9:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.8" spread="3.99"/>
                    <measurement group_id="O2" value="17.7" spread="2.67"/>
                    <measurement group_id="O3" value="19.4" spread="3.32"/>
                    <measurement group_id="O4" value="18.9" spread="2.82"/>
                    <measurement group_id="O5" value="18.1" spread="2.99"/>
                    <measurement group_id="O6" value="18.0" spread="2.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week1 13:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.8" spread="3.66"/>
                    <measurement group_id="O2" value="17.5" spread="2.25"/>
                    <measurement group_id="O3" value="18.7" spread="3.28"/>
                    <measurement group_id="O4" value="18.6" spread="3.29"/>
                    <measurement group_id="O5" value="17.1" spread="2.65"/>
                    <measurement group_id="O6" value="17.6" spread="3.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week1 17:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.6" spread="3.94"/>
                    <measurement group_id="O2" value="17.4" spread="2.43"/>
                    <measurement group_id="O3" value="18.1" spread="2.94"/>
                    <measurement group_id="O4" value="18.5" spread="3.23"/>
                    <measurement group_id="O5" value="16.9" spread="2.96"/>
                    <measurement group_id="O6" value="17.2" spread="2.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2 9:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.7" spread="3.70"/>
                    <measurement group_id="O2" value="17.6" spread="3.33"/>
                    <measurement group_id="O3" value="19.4" spread="3.62"/>
                    <measurement group_id="O4" value="18.7" spread="2.73"/>
                    <measurement group_id="O5" value="17.9" spread="3.11"/>
                    <measurement group_id="O6" value="18.3" spread="3.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2 13:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.0" spread="3.13"/>
                    <measurement group_id="O2" value="17.4" spread="2.45"/>
                    <measurement group_id="O3" value="18.2" spread="2.93"/>
                    <measurement group_id="O4" value="18.1" spread="2.77"/>
                    <measurement group_id="O5" value="17.2" spread="2.57"/>
                    <measurement group_id="O6" value="17.6" spread="2.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week2 17:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.9" spread="3.93"/>
                    <measurement group_id="O2" value="16.9" spread="2.49"/>
                    <measurement group_id="O3" value="18.2" spread="2.94"/>
                    <measurement group_id="O4" value="17.8" spread="2.33"/>
                    <measurement group_id="O5" value="16.7" spread="2.89"/>
                    <measurement group_id="O6" value="17.3" spread="2.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Diurnal Intraocular Pressure in the Study Eye at Each Post-baseline Visit</title>
        <description>Mean Diurnal IOP was defined as the mean of the IOP values at the three schedules timepoints (9:00, 13:00 and 17:00) at that visit for that subject.</description>
        <time_frame>Week 1, Week 2, Week 6 and Month 3.</time_frame>
        <population>The number of participants is reduced due to missing data.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo (Vehicle of DE-126) Followed by High Dose of DE-126</title>
            <description>Vehicle of DE-126 Ophthalmic Solution, high dose of DE-126 Ophthalmic Solution: Vehicle of DE-126 Ophthalmic Solution dosed once daily for 6weeks, followed by high dose of DE-126 dosed once daily for 6 additional weeks</description>
          </group>
          <group group_id="O2">
            <title>0.005% Latanoprost</title>
            <description>0.005% Latanoprost Ophthalmic Solution: 0.005% Latanoprost Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O3">
            <title>Ultra-low Dose 0.0005% DE-126</title>
            <description>Topical ultra-low dose of DE-126 Ophthalmic Solution: Topical ultra-low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O4">
            <title>Low Dose 0.001% DE-126</title>
            <description>Topical low dose of DE-126 Ophthalmic Solution: Topical low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O5">
            <title>Medium Dose 0.002% DE-126</title>
            <description>Topical medium dose of DE-126 Ophthalmic Solution: Topical medium dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O6">
            <title>High Dose 0.003% DE-126</title>
            <description>Topical high dose of DE-126 Ophthalmic Solution: Topical high dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Diurnal Intraocular Pressure in the Study Eye at Each Post-baseline Visit</title>
          <description>Mean Diurnal IOP was defined as the mean of the IOP values at the three schedules timepoints (9:00, 13:00 and 17:00) at that visit for that subject.</description>
          <population>The number of participants is reduced due to missing data.</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="44"/>
                <count group_id="O3" value="43"/>
                <count group_id="O4" value="43"/>
                <count group_id="O5" value="44"/>
                <count group_id="O6" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Week 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.4" spread="3.48"/>
                    <measurement group_id="O2" value="17.5" spread="2.12"/>
                    <measurement group_id="O3" value="18.8" spread="2.95"/>
                    <measurement group_id="O4" value="18.7" spread="2.88"/>
                    <measurement group_id="O5" value="17.4" spread="2.64"/>
                    <measurement group_id="O6" value="17.6" spread="2.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.2" spread="3.33"/>
                    <measurement group_id="O2" value="17.3" spread="2.51"/>
                    <measurement group_id="O3" value="18.6" spread="2.92"/>
                    <measurement group_id="O4" value="18.2" spread="2.37"/>
                    <measurement group_id="O5" value="17.3" spread="2.58"/>
                    <measurement group_id="O6" value="17.7" spread="2.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.7" spread="2.90"/>
                    <measurement group_id="O2" value="17.3" spread="2.80"/>
                    <measurement group_id="O3" value="18.4" spread="2.40"/>
                    <measurement group_id="O4" value="18.1" spread="2.50"/>
                    <measurement group_id="O5" value="17.5" spread="2.69"/>
                    <measurement group_id="O6" value="17.8" spread="2.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.1" spread="3.14"/>
                    <measurement group_id="O2" value="17.5" spread="2.98"/>
                    <measurement group_id="O3" value="18.8" spread="2.66"/>
                    <measurement group_id="O4" value="18.4" spread="2.94"/>
                    <measurement group_id="O5" value="17.2" spread="2.47"/>
                    <measurement group_id="O6" value="18.6" spread="2.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline (CFB) in Mean Diurnal Intraocular Pressure in the Study Eye at Each Post-baseline Visit</title>
        <description>Mean Diurnal IOP was defined as the mean of the IOP values at the three schedules timepoints (9:00, 13:00 and 17:00) at that visit for that subject.</description>
        <time_frame>Week 1, Week 2, Week 6 and Month 3.</time_frame>
        <population>The number of participants is reduced due to missing data.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo (Vehicle of DE-126) Followed by High Dose of DE-126</title>
            <description>Vehicle of DE-126 Ophthalmic Solution, high dose of DE-126 Ophthalmic Solution: Vehicle of DE-126 Ophthalmic Solution dosed once daily for 6weeks, followed by high dose of DE-126 dosed once daily for 6 additional weeks</description>
          </group>
          <group group_id="O2">
            <title>0.005% Latanoprost</title>
            <description>0.005% Latanoprost Ophthalmic Solution: 0.005% Latanoprost Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O3">
            <title>Ultra-low Dose 0.0005% DE-126</title>
            <description>Topical ultra-low dose of DE-126 Ophthalmic Solution: Topical ultra-low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O4">
            <title>0.001% Low Dose DE-126</title>
            <description>Topical low dose of DE-126 Ophthalmic Solution: Topical low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O5">
            <title>Medium Dose 0.002% DE-126</title>
            <description>Topical medium dose of DE-126 Ophthalmic Solution: Topical medium dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O6">
            <title>High Dose 0.003% DE-126</title>
            <description>Topical high dose of DE-126 Ophthalmic Solution: Topical high dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline (CFB) in Mean Diurnal Intraocular Pressure in the Study Eye at Each Post-baseline Visit</title>
          <description>Mean Diurnal IOP was defined as the mean of the IOP values at the three schedules timepoints (9:00, 13:00 and 17:00) at that visit for that subject.</description>
          <population>The number of participants is reduced due to missing data.</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="44"/>
                <count group_id="O3" value="43"/>
                <count group_id="O4" value="43"/>
                <count group_id="O5" value="44"/>
                <count group_id="O6" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Week 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.1" spread="2.13"/>
                    <measurement group_id="O2" value="-6.7" spread="2.98"/>
                    <measurement group_id="O3" value="-5.5" spread="2.41"/>
                    <measurement group_id="O4" value="-5.6" spread="2.84"/>
                    <measurement group_id="O5" value="-6.7" spread="3.19"/>
                    <measurement group_id="O6" value="-6.6" spread="2.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.0" spread="2.15"/>
                    <measurement group_id="O2" value="-7.0" spread="3.13"/>
                    <measurement group_id="O3" value="-5.8" spread="3.02"/>
                    <measurement group_id="O4" value="-6.0" spread="2.35"/>
                    <measurement group_id="O5" value="-6.9" spread="2.87"/>
                    <measurement group_id="O6" value="-6.5" spread="2.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.3" spread="2.49"/>
                    <measurement group_id="O2" value="-7.0" spread="3.09"/>
                    <measurement group_id="O3" value="-5.9" spread="2.73"/>
                    <measurement group_id="O4" value="-6.1" spread="2.59"/>
                    <measurement group_id="O5" value="-6.6" spread="3.08"/>
                    <measurement group_id="O6" value="-6.4" spread="2.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.9" spread="2.65"/>
                    <measurement group_id="O2" value="-6.7" spread="3.24"/>
                    <measurement group_id="O3" value="-5.5" spread="2.11"/>
                    <measurement group_id="O4" value="-5.9" spread="2.71"/>
                    <measurement group_id="O5" value="-6.9" spread="2.96"/>
                    <measurement group_id="O6" value="-5.5" spread="2.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent Change From Baseline (CFB) in Mean Diurnal Intraocular Pressure in the Study Eye at Each Post-baseline Visit</title>
        <description>Mean Diurnal IOP was defined as the mean of the IOP values at the three schedules timepoints (9:00, 13:00 and 17:00) at that visit for that subject.</description>
        <time_frame>Week 1, Week 2, Week 6 and Month 3.</time_frame>
        <population>The number of participants is reduced due to missing data.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo (Vehicle of DE-126) Followed by High Dose of DE-126</title>
            <description>Vehicle of DE-126 Ophthalmic Solution, high dose of DE-126 Ophthalmic Solution: Vehicle of DE-126 Ophthalmic Solution dosed once daily for 6weeks, followed by high dose of DE-126 dosed once daily for 6 additional weeks</description>
          </group>
          <group group_id="O2">
            <title>0.005% Latanoprost</title>
            <description>0.005% Latanoprost Ophthalmic Solution: 0.005% Latanoprost Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O3">
            <title>Ultra-low Dose 0.0005% DE-126</title>
            <description>Topical ultra-low dose of DE-126 Ophthalmic Solution: Topical ultra-low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O4">
            <title>Low Dose 0.001% DE-126</title>
            <description>Topical low dose of DE-126 Ophthalmic Solution: Topical low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O5">
            <title>Medium Dose 0.002% DE-126</title>
            <description>Topical medium dose of DE-126 Ophthalmic Solution: Topical medium dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O6">
            <title>High Dose 0.003% DE-126</title>
            <description>Topical high dose of DE-126 Ophthalmic Solution: Topical high dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Change From Baseline (CFB) in Mean Diurnal Intraocular Pressure in the Study Eye at Each Post-baseline Visit</title>
          <description>Mean Diurnal IOP was defined as the mean of the IOP values at the three schedules timepoints (9:00, 13:00 and 17:00) at that visit for that subject.</description>
          <population>The number of participants is reduced due to missing data.</population>
          <units>Percentage of change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="44"/>
                <count group_id="O3" value="43"/>
                <count group_id="O4" value="43"/>
                <count group_id="O5" value="44"/>
                <count group_id="O6" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Week 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-8.6" spread="8.15"/>
                    <measurement group_id="O2" value="-27.3" spread="10.60"/>
                    <measurement group_id="O3" value="-22.8" spread="9.59"/>
                    <measurement group_id="O4" value="-22.9" spread="10.78"/>
                    <measurement group_id="O5" value="-27.4" spread="11.48"/>
                    <measurement group_id="O6" value="-27.0" spread="11.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-8.6" spread="8.74"/>
                    <measurement group_id="O2" value="-28.3" spread="11.05"/>
                    <measurement group_id="O3" value="-23.5" spread="11.28"/>
                    <measurement group_id="O4" value="-24.7" spread="8.90"/>
                    <measurement group_id="O5" value="-28.2" spread="10.48"/>
                    <measurement group_id="O6" value="-26.4" spread="11.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-9.4" spread="10.31"/>
                    <measurement group_id="O2" value="-28.5" spread="11.23"/>
                    <measurement group_id="O3" value="-24.0" spread="9.58"/>
                    <measurement group_id="O4" value="-25.1" spread="9.83"/>
                    <measurement group_id="O5" value="-27.2" spread="10.72"/>
                    <measurement group_id="O6" value="-26.2" spread="10.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-24.7" spread="11.26"/>
                    <measurement group_id="O2" value="-27.5" spread="12.11"/>
                    <measurement group_id="O3" value="-22.6" spread="8.22"/>
                    <measurement group_id="O4" value="-24.1" spread="10.45"/>
                    <measurement group_id="O5" value="-28.4" spread="10.54"/>
                    <measurement group_id="O6" value="-22.7" spread="10.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline (CFB) in Intraocular Pressure in the Study Eye at Three Time Points at Each Post-baseline Visit</title>
        <description>Intraocular Pressure (IOP),the fluid pressure inside the eye was measured by the Goldmann applanation tonometer in millimeters mercury (mmHg) at 3 time-points throughout the day.</description>
        <time_frame>9:00, 13:00 and 17:00 at Week 1, Week 2, Week 6 and Month 3.</time_frame>
        <population>The number of participants is reduced due to missing data.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo (Vehicle of DE-126) Followed by High Dose of DE-126</title>
            <description>Vehicle of DE-126 Ophthalmic Solution, high dose of DE-126 Ophthalmic Solution: Vehicle of DE-126 Ophthalmic Solution dosed once daily for 6weeks, followed by high dose of DE-126 dosed once daily for 6 additional weeks</description>
          </group>
          <group group_id="O2">
            <title>0.005% Latanoprost</title>
            <description>0.005% Latanoprost Ophthalmic Solution: 0.005% Latanoprost Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O3">
            <title>Ultra-low Dose 0.0005% DE-126</title>
            <description>Topical ultra-low dose of DE-126 Ophthalmic Solution: Topical ultra-low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O4">
            <title>Low Dose 0.001% DE-126</title>
            <description>Topical low dose of DE-126 Ophthalmic Solution: Topical low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O5">
            <title>Medium Dose 0.002% DE-126</title>
            <description>Topical medium dose of DE-126 Ophthalmic Solution: Topical medium dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O6">
            <title>High Dose 0.003% DE-126</title>
            <description>Topical high dose of DE-126 Ophthalmic Solution: Topical high dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline (CFB) in Intraocular Pressure in the Study Eye at Three Time Points at Each Post-baseline Visit</title>
          <description>Intraocular Pressure (IOP),the fluid pressure inside the eye was measured by the Goldmann applanation tonometer in millimeters mercury (mmHg) at 3 time-points throughout the day.</description>
          <population>The number of participants is reduced due to missing data.</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="44"/>
                <count group_id="O3" value="43"/>
                <count group_id="O4" value="43"/>
                <count group_id="O5" value="44"/>
                <count group_id="O6" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Week 1 9:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.1" spread="2.68"/>
                    <measurement group_id="O2" value="-7.3" spread="3.65"/>
                    <measurement group_id="O3" value="-5.3" spread="2.65"/>
                    <measurement group_id="O4" value="-6.0" spread="3.10"/>
                    <measurement group_id="O5" value="-6.7" spread="3.70"/>
                    <measurement group_id="O6" value="-6.6" spread="3.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 1 13:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.2" spread="2.73"/>
                    <measurement group_id="O2" value="-6.8" spread="3.35"/>
                    <measurement group_id="O3" value="-5.7" spread="2.73"/>
                    <measurement group_id="O4" value="-5.6" spread="3.26"/>
                    <measurement group_id="O5" value="-6.8" spread="3.59"/>
                    <measurement group_id="O6" value="-6.7" spread="3.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 1 17:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.8" spread="2.81"/>
                    <measurement group_id="O2" value="-6.2" spread="3.33"/>
                    <measurement group_id="O3" value="-5.6" spread="2.83"/>
                    <measurement group_id="O4" value="-5.2" spread="3.62"/>
                    <measurement group_id="O5" value="-6.7" spread="3.60"/>
                    <measurement group_id="O6" value="-6.4" spread="2.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2 9:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.9" spread="2.66"/>
                    <measurement group_id="O2" value="-7.4" spread="4.03"/>
                    <measurement group_id="O3" value="-5.5" spread="3.52"/>
                    <measurement group_id="O4" value="-6.2" spread="3.00"/>
                    <measurement group_id="O5" value="-6.9" spread="3.32"/>
                    <measurement group_id="O6" value="-6.4" spread="3.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2 13:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.8" spread="2.89"/>
                    <measurement group_id="O2" value="-6.8" spread="3.02"/>
                    <measurement group_id="O3" value="-6.2" spread="3.36"/>
                    <measurement group_id="O4" value="-6.0" spread="2.62"/>
                    <measurement group_id="O5" value="-6.8" spread="3.27"/>
                    <measurement group_id="O6" value="-6.7" spread="3.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2 17:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.4" spread="2.57"/>
                    <measurement group_id="O2" value="-6.7" spread="3.39"/>
                    <measurement group_id="O3" value="-5.7" spread="3.36"/>
                    <measurement group_id="O4" value="-5.8" spread="2.52"/>
                    <measurement group_id="O5" value="-6.9" spread="3.29"/>
                    <measurement group_id="O6" value="-6.3" spread="3.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6 9:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.0" spread="2.59"/>
                    <measurement group_id="O2" value="-7.0" spread="3.84"/>
                    <measurement group_id="O3" value="-5.7" spread="3.03"/>
                    <measurement group_id="O4" value="-6.4" spread="2.83"/>
                    <measurement group_id="O5" value="-6.1" spread="3.21"/>
                    <measurement group_id="O6" value="-6.1" spread="3.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6 13:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.1" spread="2.66"/>
                    <measurement group_id="O2" value="-7.0" spread="3.30"/>
                    <measurement group_id="O3" value="-6.1" spread="3.65"/>
                    <measurement group_id="O4" value="-6.2" spread="2.64"/>
                    <measurement group_id="O5" value="-6.8" spread="3.67"/>
                    <measurement group_id="O6" value="-6.8" spread="3.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6 17:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.7" spread="3.33"/>
                    <measurement group_id="O2" value="-6.8" spread="3.38"/>
                    <measurement group_id="O3" value="-5.9" spread="2.56"/>
                    <measurement group_id="O4" value="-5.7" spread="3.30"/>
                    <measurement group_id="O5" value="-7.0" spread="3.36"/>
                    <measurement group_id="O6" value="-6.2" spread="3.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 3 at 9:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.6" spread="3.21"/>
                    <measurement group_id="O2" value="-6.9" spread="3.84"/>
                    <measurement group_id="O3" value="-5.1" spread="2.42"/>
                    <measurement group_id="O4" value="-5.7" spread="3.08"/>
                    <measurement group_id="O5" value="-7.2" spread="3.32"/>
                    <measurement group_id="O6" value="-5.4" spread="3.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 3 at 13:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.0" spread="3.28"/>
                    <measurement group_id="O2" value="-6.9" spread="3.25"/>
                    <measurement group_id="O3" value="-5.9" spread="2.49"/>
                    <measurement group_id="O4" value="-6.0" spread="2.97"/>
                    <measurement group_id="O5" value="-6.7" spread="3.34"/>
                    <measurement group_id="O6" value="-5.5" spread="3.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 3 at 17:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.1" spread="2.74"/>
                    <measurement group_id="O2" value="-6.4" spread="3.63"/>
                    <measurement group_id="O3" value="-5.4" spread="2.74"/>
                    <measurement group_id="O4" value="-5.8" spread="3.12"/>
                    <measurement group_id="O5" value="-6.9" spread="3.48"/>
                    <measurement group_id="O6" value="-5.5" spread="2.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent Change From Baseline (CFB) in Intraocular Pressure in the Study Eye at Three Time Points at Each Post-baseline Visit</title>
        <description>Intraocular Pressure (IOP),the fluid pressure inside the eye was measured by the Goldmann applanation tonometer in millimeters mercury (mmHg) at 3 time-points throughout the day.</description>
        <time_frame>9:00, 13:00 and 17:00 at Week 1, Week 2, Week 6 and Month 3.</time_frame>
        <population>The number of participants is reduced due to missing data.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo (Vehicle of DE-126) Followed by High Dose of DE-126</title>
            <description>Vehicle of DE-126 Ophthalmic Solution, high dose of DE-126 Ophthalmic Solution: Vehicle of DE-126 Ophthalmic Solution dosed once daily for 6weeks, followed by high dose of DE-126 dosed once daily for 6 additional weeks</description>
          </group>
          <group group_id="O2">
            <title>0.005% Latanoprost</title>
            <description>0.005% Latanoprost Ophthalmic Solution: 0.005% Latanoprost Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O3">
            <title>Ultra-low Dose 0.0005% DE-126</title>
            <description>Topical ultra-low dose of DE-126 Ophthalmic Solution: Topical ultra-low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O4">
            <title>Low Dose 0.001% DE-126</title>
            <description>Topical low dose of DE-126 Ophthalmic Solution: Topical low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O5">
            <title>Medium Dose 0.002% DE-126</title>
            <description>Topical medium dose of DE-126 Ophthalmic Solution: Topical medium dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O6">
            <title>High Dose 0.003% DE-126</title>
            <description>Topical high dose of DE-126 Ophthalmic Solution: Topical high dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Change From Baseline (CFB) in Intraocular Pressure in the Study Eye at Three Time Points at Each Post-baseline Visit</title>
          <description>Intraocular Pressure (IOP),the fluid pressure inside the eye was measured by the Goldmann applanation tonometer in millimeters mercury (mmHg) at 3 time-points throughout the day.</description>
          <population>The number of participants is reduced due to missing data.</population>
          <units>Percentage of change in IOP</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="44"/>
                <count group_id="O3" value="43"/>
                <count group_id="O4" value="43"/>
                <count group_id="O5" value="44"/>
                <count group_id="O6" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Week 1 9:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-8.7" spread="9.58"/>
                    <measurement group_id="O2" value="-28.5" spread="12.00"/>
                    <measurement group_id="O3" value="-21.6" spread="10.44"/>
                    <measurement group_id="O4" value="-23.7" spread="11.01"/>
                    <measurement group_id="O5" value="-26.5" spread="12.64"/>
                    <measurement group_id="O6" value="-26.5" spread="11.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 1 13:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.3" spread="10.75"/>
                    <measurement group_id="O2" value="-27.3" spread="11.41"/>
                    <measurement group_id="O3" value="-23.3" spread="11.09"/>
                    <measurement group_id="O4" value="-22.8" spread="12.54"/>
                    <measurement group_id="O5" value="-28.0" spread="12.43"/>
                    <measurement group_id="O6" value="-27.0" spread="13.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 1 17:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-11.5" spread="10.56"/>
                    <measurement group_id="O2" value="-25.7" spread="12.62"/>
                    <measurement group_id="O3" value="-23.4" spread="10.96"/>
                    <measurement group_id="O4" value="-21.5" spread="14.33"/>
                    <measurement group_id="O5" value="-27.9" spread="13.10"/>
                    <measurement group_id="O6" value="-26.8" spread="11.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2 9:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-7.8" spread="10.30"/>
                    <measurement group_id="O2" value="-28.9" spread="13.13"/>
                    <measurement group_id="O3" value="-21.7" spread="13.84"/>
                    <measurement group_id="O4" value="-24.5" spread="10.62"/>
                    <measurement group_id="O5" value="-27.4" spread="11.69"/>
                    <measurement group_id="O6" value="-25.6" spread="13.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2 13:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-7.5" spread="12.08"/>
                    <measurement group_id="O2" value="-27.8" spread="10.89"/>
                    <measurement group_id="O3" value="-25.1" spread="12.42"/>
                    <measurement group_id="O4" value="-24.9" spread="10.09"/>
                    <measurement group_id="O5" value="-27.8" spread="11.83"/>
                    <measurement group_id="O6" value="-27.0" spread="11.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2 17:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-9.9" spread="10.16"/>
                    <measurement group_id="O2" value="-27.8" spread="12.69"/>
                    <measurement group_id="O3" value="-23.5" spread="12.42"/>
                    <measurement group_id="O4" value="-24.4" spread="9.53"/>
                    <measurement group_id="O5" value="-28.8" spread="12.48"/>
                    <measurement group_id="O6" value="-26.3" spread="11.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6 9:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-8.4" spread="10.71"/>
                    <measurement group_id="O2" value="-27.5" spread="12.44"/>
                    <measurement group_id="O3" value="-22.8" spread="10.71"/>
                    <measurement group_id="O4" value="-25.3" spread="9.93"/>
                    <measurement group_id="O5" value="-24.4" spread="11.45"/>
                    <measurement group_id="O6" value="-24.3" spread="13.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6 13:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-8.6" spread="10.89"/>
                    <measurement group_id="O2" value="-28.8" spread="12.25"/>
                    <measurement group_id="O3" value="-24.5" spread="12.69"/>
                    <measurement group_id="O4" value="-25.6" spread="9.85"/>
                    <measurement group_id="O5" value="-27.7" spread="12.16"/>
                    <measurement group_id="O6" value="-27.8" spread="11.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6 17:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-11.1" spread="13.12"/>
                    <measurement group_id="O2" value="-28.4" spread="12.62"/>
                    <measurement group_id="O3" value="-24.6" spread="9.63"/>
                    <measurement group_id="O4" value="-24.0" spread="12.84"/>
                    <measurement group_id="O5" value="-29.4" spread="11.86"/>
                    <measurement group_id="O6" value="-26.1" spread="12.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 3 at 9:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-23.3" spread="13.33"/>
                    <measurement group_id="O2" value="-27.3" spread="13.11"/>
                    <measurement group_id="O3" value="-20.6" spread="9.64"/>
                    <measurement group_id="O4" value="-22.8" spread="11.48"/>
                    <measurement group_id="O5" value="-28.8" spread="11.66"/>
                    <measurement group_id="O6" value="-21.4" spread="12.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 3 at 13:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-25.3" spread="13.15"/>
                    <measurement group_id="O2" value="-28.2" spread="12.30"/>
                    <measurement group_id="O3" value="-24.2" spread="10.00"/>
                    <measurement group_id="O4" value="-24.8" spread="11.33"/>
                    <measurement group_id="O5" value="-27.3" spread="11.73"/>
                    <measurement group_id="O6" value="-22.5" spread="13.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 3 at 17:00</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-25.4" spread="11.12"/>
                    <measurement group_id="O2" value="-26.8" spread="14.63"/>
                    <measurement group_id="O3" value="-22.7" spread="10.37"/>
                    <measurement group_id="O4" value="-24.3" spread="12.06"/>
                    <measurement group_id="O5" value="-28.7" spread="12.82"/>
                    <measurement group_id="O6" value="-23.4" spread="11.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Subjects With Mean Diurnal Intraocular Pressure Reduction From Baseline ≥ 20%, 25% and 30% in the Study Eye at Each Post-baseline Visit</title>
        <description>A Subject was a responder if the percent reduction from baseline in mean diurnal IOP in the study eye was ≥ 20%.&#xD;
A Subject was a responder if the percent reduction from baseline in mean diurnal IOP in the study eye was ≥ 25%.&#xD;
A Subject was a responder if the percent reduction from baseline in mean diurnal IOP in the study eye was ≥ 30%.</description>
        <time_frame>WeeK 1, Week 2, Week 6 and Month 3.</time_frame>
        <population>The number of participants is reduced due to missing data.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo (Vehicle of DE-126) Followed by High Dose of DE-126</title>
            <description>Vehicle of DE-126 Ophthalmic Solution, high dose of DE-126 Ophthalmic Solution: Vehicle of DE-126 Ophthalmic Solution dosed once daily for 6weeks, followed by high dose of DE-126 dosed once daily for 6 additional weeks</description>
          </group>
          <group group_id="O2">
            <title>0.005% Latanoprost</title>
            <description>0.005% Latanoprost Ophthalmic Solution: 0.005% Latanoprost Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O3">
            <title>Ultra-low Dose 0.0005% DE-126</title>
            <description>Topical ultra-low dose of DE-126 Ophthalmic Solution: Topical ultra-low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O4">
            <title>Low Dose 0.001% DE-126</title>
            <description>Topical low dose of DE-126 Ophthalmic Solution: Topical low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O5">
            <title>Medium Dose 0.002% DE-126</title>
            <description>Topical medium dose of DE-126 Ophthalmic Solution: Topical medium dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O6">
            <title>High Dose 0.003% DE-126</title>
            <description>Topical high dose of DE-126 Ophthalmic Solution: Topical high dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Subjects With Mean Diurnal Intraocular Pressure Reduction From Baseline ≥ 20%, 25% and 30% in the Study Eye at Each Post-baseline Visit</title>
          <description>A Subject was a responder if the percent reduction from baseline in mean diurnal IOP in the study eye was ≥ 20%.&#xD;
A Subject was a responder if the percent reduction from baseline in mean diurnal IOP in the study eye was ≥ 25%.&#xD;
A Subject was a responder if the percent reduction from baseline in mean diurnal IOP in the study eye was ≥ 30%.</description>
          <population>The number of participants is reduced due to missing data.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="44"/>
                <count group_id="O3" value="42"/>
                <count group_id="O4" value="43"/>
                <count group_id="O5" value="44"/>
                <count group_id="O6" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Week 1- At Least 20% Reduction</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="36"/>
                    <measurement group_id="O3" value="22"/>
                    <measurement group_id="O4" value="28"/>
                    <measurement group_id="O5" value="31"/>
                    <measurement group_id="O6" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 1- At Least 25% Reduction</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="23"/>
                    <measurement group_id="O3" value="18"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="25"/>
                    <measurement group_id="O6" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 1- At Least 30% Reduction</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2- At Least 20% Reduction</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="38"/>
                    <measurement group_id="O3" value="27"/>
                    <measurement group_id="O4" value="26"/>
                    <measurement group_id="O5" value="31"/>
                    <measurement group_id="O6" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2- At Least 25% Reduction</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="27"/>
                    <measurement group_id="O3" value="21"/>
                    <measurement group_id="O4" value="22"/>
                    <measurement group_id="O5" value="27"/>
                    <measurement group_id="O6" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2- At Least 30% Reduction</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="20"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="17"/>
                    <measurement group_id="O6" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6- At Least 20% Reduction</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="37"/>
                    <measurement group_id="O3" value="30"/>
                    <measurement group_id="O4" value="28"/>
                    <measurement group_id="O5" value="30"/>
                    <measurement group_id="O6" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6- At Least 25% Reduction</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="26"/>
                    <measurement group_id="O3" value="17"/>
                    <measurement group_id="O4" value="22"/>
                    <measurement group_id="O5" value="22"/>
                    <measurement group_id="O6" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6- At Least 30% Reduction</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="19"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="18"/>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 3- At Least 20% Reduction</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="36"/>
                    <measurement group_id="O3" value="28"/>
                    <measurement group_id="O4" value="27"/>
                    <measurement group_id="O5" value="37"/>
                    <measurement group_id="O6" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 3- At Least 25% Reduction</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="23"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="22"/>
                    <measurement group_id="O5" value="28"/>
                    <measurement group_id="O6" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 3- At Least 30% Reduction</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="16"/>
                    <measurement group_id="O6" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Subjects With Mean Diurnal Intraocular Pressure ≤ 18 mmHg in the Study Eye at Each Post-baseline Visit</title>
        <description>A subject was a responder if the mean diurnal IOP in the study eye was ≤ 18 mmHg.</description>
        <time_frame>Week 1, Week 2, Week 6 and Month 3.</time_frame>
        <population>The number of participants is reduced due to missing data.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo (Vehicle of DE-126) Followed by High Dose of DE-126</title>
            <description>Vehicle of DE-126 Ophthalmic Solution, high dose of DE-126 Ophthalmic Solution: Vehicle of DE-126 Ophthalmic Solution dosed once daily for 6weeks, followed by high dose of DE-126 dosed once daily for 6 additional weeks</description>
          </group>
          <group group_id="O2">
            <title>0.005% Latanoprost</title>
            <description>0.005% Latanoprost Ophthalmic Solution: 0.005% Latanoprost Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O3">
            <title>Ultra-low Dose 0.0005% DE-126</title>
            <description>Topical ultra-low dose of DE-126 Ophthalmic Solution: Topical ultra-low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O4">
            <title>Low Dose 0.001% DE-126</title>
            <description>Topical low dose of DE-126 Ophthalmic Solution: Topical low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O5">
            <title>Medium Dose 0.002% DE-126</title>
            <description>Topical medium dose of DE-126 Ophthalmic Solution: Topical medium dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
          <group group_id="O6">
            <title>High Dose 0.003% DE-126</title>
            <description>Topical high dose of DE-126 Ophthalmic Solution: Topical high dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Subjects With Mean Diurnal Intraocular Pressure ≤ 18 mmHg in the Study Eye at Each Post-baseline Visit</title>
          <description>A subject was a responder if the mean diurnal IOP in the study eye was ≤ 18 mmHg.</description>
          <population>The number of participants is reduced due to missing data.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="44"/>
                <count group_id="O3" value="43"/>
                <count group_id="O4" value="43"/>
                <count group_id="O5" value="44"/>
                <count group_id="O6" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Week 1 -Reduced to 18 mmHg or Lower</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="29"/>
                    <measurement group_id="O3" value="16"/>
                    <measurement group_id="O4" value="20"/>
                    <measurement group_id="O5" value="26"/>
                    <measurement group_id="O6" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2 -Reduced to 18 mmHg or Lower</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="30"/>
                    <measurement group_id="O3" value="18"/>
                    <measurement group_id="O4" value="22"/>
                    <measurement group_id="O5" value="27"/>
                    <measurement group_id="O6" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6 -Reduced to 18 mmHg or Lower</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="27"/>
                    <measurement group_id="O3" value="24"/>
                    <measurement group_id="O4" value="22"/>
                    <measurement group_id="O5" value="25"/>
                    <measurement group_id="O6" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 3 -Reduced to 18 mmHg or Lower</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="30"/>
                    <measurement group_id="O3" value="18"/>
                    <measurement group_id="O4" value="19"/>
                    <measurement group_id="O5" value="27"/>
                    <measurement group_id="O6" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Reporting time frame is from Inform Consent to end of the study at Month3.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Placebo P1</title>
          <description>Vehicle of DE-126 Ophthalmic Solution, high dose of DE-126 Ophthalmic Solution: Vehicle of DE-126 Ophthalmic Solution dosed once daily for 6weeks.</description>
        </group>
        <group group_id="E2">
          <title>Placebo P2</title>
          <description>Vehicle of DE-126 Ophthalmic Solution, high dose of DE-126 Ophthalmic Solution: Vehicle of DE-126 Ophthalmic Solution treatment arm dosed by high dose of DE-126 dosed once daily from w6 to month3.</description>
        </group>
        <group group_id="E3">
          <title>0.005% Latanoprost</title>
          <description>0.005% Latanoprost Ophthalmic Solution: 0.005% Latanoprost Ophthalmic Solution dosed once daily for 12 weeks</description>
        </group>
        <group group_id="E4">
          <title>Ultra-low Dose DE-126</title>
          <description>Topical ultra-low dose of DE-126 Ophthalmic Solution: Topical ultra-low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
        </group>
        <group group_id="E5">
          <title>Low Dose DE-126</title>
          <description>Topical low dose of DE-126 Ophthalmic Solution: Topical low dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
        </group>
        <group group_id="E6">
          <title>Medium Dose DE-126</title>
          <description>Topical medium dose of DE-126 Ophthalmic Solution: Topical medium dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
        </group>
        <group group_id="E7">
          <title>High Dose of DE-126</title>
          <description>Topical high dose of DE-126 Ophthalmic Solution: Topical high dose of DE-126 Ophthalmic Solution dosed once daily for 12 weeks</description>
        </group>
        <group group_id="E8">
          <title>High Dose of DE-126 Total</title>
          <description>Summarizes columns High dose of DE-126 and Placebo P2</description>
        </group>
        <group group_id="E9">
          <title>DE-126 Total</title>
          <description>Total summarizes columns Ultra Low Dose, Low Dose, Medium Dose, High Dose and Placebo P2.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="195"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="195"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="195"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="18" subjects_at_risk="44"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="43"/>
                <counts group_id="E5" subjects_affected="12" subjects_at_risk="43"/>
                <counts group_id="E6" subjects_affected="10" subjects_at_risk="44"/>
                <counts group_id="E7" subjects_affected="12" subjects_at_risk="45"/>
                <counts group_id="E8" subjects_affected="22" subjects_at_risk="65"/>
                <counts group_id="E9" subjects_affected="57" subjects_at_risk="195"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="195"/>
              </event>
              <event>
                <sub_title>Conjunctival Hyperaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E3" events="13" subjects_affected="12" subjects_at_risk="44"/>
                <counts group_id="E4" events="8" subjects_affected="5" subjects_at_risk="43"/>
                <counts group_id="E5" events="5" subjects_affected="5" subjects_at_risk="43"/>
                <counts group_id="E6" events="10" subjects_affected="9" subjects_at_risk="44"/>
                <counts group_id="E7" events="8" subjects_affected="7" subjects_at_risk="45"/>
                <counts group_id="E8" events="10" subjects_affected="9" subjects_at_risk="65"/>
                <counts group_id="E9" events="33" subjects_affected="28" subjects_at_risk="195"/>
              </event>
              <event>
                <sub_title>Eye Irritation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="4" subjects_affected="3" subjects_at_risk="43"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="65"/>
                <counts group_id="E9" events="4" subjects_affected="3" subjects_at_risk="195"/>
              </event>
              <event>
                <sub_title>Eye Pruritus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="44"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="43"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E7" events="5" subjects_affected="5" subjects_at_risk="45"/>
                <counts group_id="E8" events="5" subjects_affected="5" subjects_at_risk="65"/>
                <counts group_id="E9" events="8" subjects_affected="8" subjects_at_risk="195"/>
              </event>
              <event>
                <sub_title>Growth Of Eyelashes</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="43"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="43"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E9" events="6" subjects_affected="6" subjects_at_risk="195"/>
              </event>
              <event>
                <sub_title>Lacrimation Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="44"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E9" events="4" subjects_affected="3" subjects_at_risk="195"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Instillation Site Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E6" events="3" subjects_affected="3" subjects_at_risk="44"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E9" events="5" subjects_affected="5" subjects_at_risk="195"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="195"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Alveolar Osteitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="195"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E8" events="3" subjects_affected="3" subjects_at_risk="65"/>
                <counts group_id="E9" events="3" subjects_affected="3" subjects_at_risk="195"/>
              </event>
              <event>
                <sub_title>Upper Respiratory Tract Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="43"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E9" events="5" subjects_affected="5" subjects_at_risk="195"/>
              </event>
              <event>
                <sub_title>Viral Upper Respiratory Tract Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="43"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="43"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="45"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="65"/>
                <counts group_id="E9" events="8" subjects_affected="8" subjects_at_risk="195"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Hepatic Enzyme Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="195"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertonic Bladder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="195"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Skin Lesion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="195"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Phlebitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="65"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="195"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>If Institution/Principal Investigator wishes to publish findings, they must submit draft to Santen at least 30 days prior, deleting Confidential Information if requested. Santen must be allowed up to ninety (90) days to determine if patent application is to be filed. Santen has right to first publication of Multi-Center Research results, but if publication doesn't occur within 12 months after completion, Institution/Principal Investigator may individually publish site's results.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>R&amp;D Quality Manager</name_or_title>
      <organization>Santen Inc</organization>
      <phone>+1 415 268 9199</phone>
      <email>clinicaltrials@santen.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

